Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595764 · ClinicalTrials.gov registry record · Phase 4
Counseling for Primary Care Office-based Buprenorphine
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 141
- Enrollment target
NCT00595764 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 141 participants.
The verdict
NCT00595764, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 141 participants
- Enrollment target
Study Summary
The major goal is to determine whether adding cognitive behavioral therapy to physician management will increase the efficacy of buprenorphine/naloxone treatment in an office-based primary care setting.
Interventions
- BEHAVIORAL Manual-guided Physician Management (PM)
- BEHAVIORAL Physician Management (PM) combined with on-site manual-guided Cognitive Behavioral Therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595764
The ClinicalTrials.gov registry entry for NCT00595764 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manual-guided Physician Management (PM) is the first listed.
NCT00595764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00595764 about?
NCT00595764 is a clinical study titled "Counseling for Primary Care Office-based Buprenorphine". The major goal is to determine whether adding cognitive behavioral therapy to physician management will increase the efficacy of buprenorphine/naloxone treatment in an office-based primary care setting.
What is the current status of trial NCT00595764?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 141 participants. The study started on 2005-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00595764?
The interventions under investigation include: Manual-guided Physician Management (PM) (BEHAVIORAL), Physician Management (PM) combined with on-site manual-guided Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00595764?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.